Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    February 2024
  1. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    PI-RADS Upgrading Rules: Impact on Prostate Cancer Detection and Biopsy Avoidance of MRI-Directed Diagnostic Pathways.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30611.
    PubMed     Abstract available


    January 2024
  2. LAWRENCE EM
    Editorial Comment: Similar Upgrade and Downgrade Rates Between PI-RADS Version 2.0 and Version 2.1.
    AJR Am J Roentgenol. 2024;222:e2330325.
    PubMed    


    December 2023
  3. BIROSH A, Miranda ES, Breau RH, McInnes MDF, et al
    Multiparametric Versus Biparametric Prostate MRI: Comparison of NPV for Clinically Significant Prostate Cancer.
    AJR Am J Roentgenol. 2023 Dec 13. doi: 10.2214/AJR.23.30496.
    PubMed    


    September 2023
  4. YILMAZ EC, Lin Y, Belue MJ, Harmon SA, et al
    PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
    AJR Am J Roentgenol. 2023 Sep 20. doi: 10.2214/AJR.23.29964.
    PubMed     Abstract available


    July 2023
  5. WU CJ
    Editorial Comment: MRI Improves Preoperative Prognosis Prediction in Patients With Prostate Cancer.
    AJR Am J Roentgenol. 2023 Jul 19. doi: 10.2214/AJR.23.29909.
    PubMed    


  6. MERRIMAN KM, Harmon SA, Belue MJ, Yilmaz EC, et al
    Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
    AJR Am J Roentgenol. 2023 Jul 5. doi: 10.2214/AJR.23.29609.
    PubMed     Abstract available


    June 2023
  7. SANMUGALINGAM N, Sushentsev N, Lee KL, Caglic I, et al
    The PRECISE Recommendations for Prostate MRI in Patients on Active Surveillance for Prostate Cancer: A Critical Review.
    AJR Am J Roentgenol. 2023 Jun 21. doi: 10.2214/AJR.23.29518.
    PubMed     Abstract available


    May 2023
  8. GOWDA NK
    Editorial Comment: Biopsy of Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Is Safe and Diagnostic.
    AJR Am J Roentgenol. 2023;220:726.
    PubMed    


  9. O'SHEA A, Iravani A, Saboury B, Jadvar H, et al
    Integrating Theranostics Into Patient Care Pathways: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023;220:619-629.
    PubMed     Abstract available


    February 2023
  10. MARGOLIS DJA
    Editorial Comment: Posttreatment Prostate MRI Is Not "RAD"...It's "PIRRfect".
    AJR Am J Roentgenol. 2023 Feb 15. doi: 10.2214/AJR.23.29133.
    PubMed    


  11. ABREU-GOMEZ J, Dias AB, Ghai S
    PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy-A Review.
    AJR Am J Roentgenol. 2023 Feb 1. doi: 10.2214/AJR.22.28665.
    PubMed     Abstract available


    January 2023
  12. WARD RD, Purysko AS
    Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective Alternative to PSA Screening and Standard Biopsy.
    AJR Am J Roentgenol. 2023 Jan 18. doi: 10.2214/AJR.23.29011.
    PubMed    


  13. SINHA P, Lamonica DM
    Beyond the AJR: (99m)Tc-MDP Bone Scintigraphy-Has It Met Its Match?
    AJR Am J Roentgenol. 2023 Jan 11. doi: 10.2214/AJR.23.28978.
    PubMed    


    December 2022
  14. KAPPLINGER JD, Lima LMF, Packard AT, Nathan MA, et al
    Safety and Efficacy of CT-Guided Percutaneous Biopsy of Suspicious Subcentimeter Pelvic and Retroperitoneal Lymph Nodes Detected by (11)C-Choline PET in Patients With Prostate Cancer.
    AJR Am J Roentgenol. 2022 Dec 7. doi: 10.2214/AJR.22.28321.
    PubMed     Abstract available


    September 2022
  15. AHLAWAT S, Debs P, Amini B, Lecouvet FE, et al
    Clinical Applications and Controversies of Whole-Body MRI: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 Sep 28. doi: 10.2214/AJR.22.28229.
    PubMed     Abstract available


    August 2022
  16. GHAI S, Perlis N
    Beyond the AJR: MRI-Guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
    AJR Am J Roentgenol. 2022 Aug 24. doi: 10.2214/AJR.22.28413.
    PubMed    


    June 2022
  17. WOO S
    Editorial Comment: Time to Ditch Bone Scans for Prostate Cancer Workup in the Era of PSMA PET/CT?
    AJR Am J Roentgenol. 2022 Jun 29:11. doi: 10.2214/AJR.22.27867.
    PubMed    


  18. DAS JP, Woo S
    Multiparametric Prostate MRI for Biochemical Failure in the Era of Targeted PET Radiotracers: Point-MRI May No Longer Be Needed in Patient Workup.
    AJR Am J Roentgenol. 2022 Jun 1. doi: 10.2214/AJR.22.27882.
    PubMed    


  19. PECORARO M, Panebianco V
    Multiparametric Prostate MRI for Biochemical Failure in the Era of Targeted PET Radiotracers: Counterpoint-MRI Remains a Specific and Accessible Test for Targeted Management.
    AJR Am J Roentgenol. 2022 Jun 1. doi: 10.2214/AJR.22.28042.
    PubMed    


    May 2022
  20. BARRETT T, Ghafoor S, Gupta RT, Kim CK, et al
    Prostate MRI Qualification: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27615.
    PubMed     Abstract available


  21. ZHU A, Hu JC
    Beyond the AJR: Racial Disparities in Prostate MRI Utilization.
    AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27889.
    PubMed    


    April 2022
  22. ZHAO G, Ji B
    Head-to-Head Comparison of (68)Ga-PSMA-11 PET/CT and (99m)Tc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A Meta-Analysis.
    AJR Am J Roentgenol. 2022 Apr 20. doi: 10.2214/AJR.21.27323.
    PubMed     Abstract available


  23. YANO M
    Editorial Comment: What Is Prostate MRI Interpretation Experience?
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27781.
    PubMed    


    March 2022
  24. SALKA BR, Shankar PR, Troost JP, Khalatbari S, et al
    Effect of Prostate MRI Interpretation Experience on PPV Using PI-RADS Version 2: A 6-Year Assessment Among Eight Fellowship-Trained Radiologists.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27421.
    PubMed     Abstract available


  25. COSTA DN, Menard A, Moore CM, Tamada T, et al
    The Global Reading Room: MRI-Targeted Prostate Biopsy After Proctocolectomy.
    AJR Am J Roentgenol. 2022 Mar 16. doi: 10.2214/AJR.22.27619.
    PubMed    


    December 2021
  26. CUOCOLO R
    Editorial Comment: Prostate Cancer Detection With Machine Learning-Still More Challenges Than Opportunities.
    AJR Am J Roentgenol. 2021 Dec 22. doi: 10.2214/AJR.21.27221.
    PubMed    


  27. TURKBEY B, Haider MA
    Artificial Intelligence (AI) for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the AJR Special Series on AI Applications.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.26917.
    PubMed     Abstract available


    November 2021
  28. GAN JM, Kikano EG, Smith DA, Rao S, et al
    Clinically Significant Prostate Cancer Detection After A Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26569.
    PubMed     Abstract available


    October 2021
  29. SEYFRIED N, Mahran A, Panda A, Obmann VC, et al
    Diagnostic Yield of Incremental Biopsy Cores and Second Lesion Sampling for In-Gantry MRI-Guided Prostate Biopsy.
    AJR Am J Roentgenol. 2021;217:908-918.
    PubMed     Abstract available


    August 2021
  30. SHRIKI J
    Editorial Comment: Directions for Further Literature on the Role of PET in Biochemical Recurrence of Prostate Cancer.
    AJR Am J Roentgenol. 2021 Aug 25. doi: 10.2214/AJR.21.26706.
    PubMed    


  31. DUAN H, Baratto L, Hatami N, Liang T, et al
    Reduced Acquisition Time Per Bed Position for PET/MRI Using (68)Ga-RM2 or (68)Ga-PSMA11 in Patients With Prostate Cancer: A Retrospective Analysis.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.25961.
    PubMed     Abstract available


  32. PATRA A, Khasawneh H, Suman G, Nathan MA, et al
    Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer: (11)C-Choline PET/CT Imaging With Multimodality Correlation.
    AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26426.
    PubMed     Abstract available


  33. GALGANO SJ, McConathy J
    Beyond the AJR: Integrating (18)F-Fluciclovine PET/CT Into Salvage Radiotherapy Planning for Recurrent Prostate Cancer Reduces Rates of Biochemical Failure (EMPIRE-1 Trial).
    AJR Am J Roentgenol. 2021 Aug 4. doi: 10.2214/AJR.21.26599.
    PubMed    


    July 2021
  34. TURKBEY B
    Editorial Comment: MRI for Benign Prostatic Hyperplasia-An Underutilized Imaging Opportunity.
    AJR Am J Roentgenol. 2021 Jul 28. doi: 10.2214/AJR.21.26603.
    PubMed    


  35. CHANG SD, Ghai S, Kim CK, Oto A, et al
    MRI-Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2021 Jul 14. doi: 10.2214/AJR.21.26154.
    PubMed     Abstract available


  36. BHAYANA R, O'Shea A, Anderson MA, Bradley WR, et al
    PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
    AJR Am J Roentgenol. 2021;217:141-151.
    PubMed     Abstract available


    June 2021
  37. GAFFNEY CD, Cai P, Li D, Margolis D, et al
    Increasing Utilization of MRI Before Prostate Biopsy in Black and Non-Black Men: An Analysis of the SEER-Medicare Cohort.
    AJR Am J Roentgenol. 2021 Jun 23:1-6. doi: 10.2214/AJR.20.23462.
    PubMed     Abstract available


    May 2021
  38. WEI CG, Zhang YY, Pan P, Chen T, et al
    Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
    AJR Am J Roentgenol. 2021;216:1247-1256.
    PubMed     Abstract available


    April 2021
  39. DENIFFEL D, Haider MA
    Beyond the AJR: "Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study".
    AJR Am J Roentgenol. 2021 Apr 28. doi: 10.2214/AJR.21.26048.
    PubMed    


  40. SCIALPI M, Scialpi P, Blasi AD
    Prostate Biparametric MRI: PI-RADS Committee Position and Perspectives.
    AJR Am J Roentgenol. 2021 Apr 21:W1. doi: 10.2214/AJR.21.25443.
    PubMed    


  41. HUANG YH, Ozutemiz C, Rubin N, Schat R, et al
    Impact of 18 French Rectal Tube Placement on Image Quality of Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2021 Apr 14. doi: 10.2214/AJR.21.25732.
    PubMed     Abstract available


  42. TURKBEY B
    Beyond the AJR: "Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy with Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer A Phase 3 Randomized Clinical Trial".
    AJR Am J Roentgenol. 2021 Apr 7. doi: 10.2214/AJR.21.25954.
    PubMed    


    March 2021
  43. PRINCE M, Foster BR, Kaempf A, Liu JJ, et al
    In-Bore Versus Fusion MRI-Targeted Prostate Biopsy of PI-RADS Category 4 or 5 Lesions: A Retrospective Comparative Analysis Using Propensity Score Weighting.
    AJR Am J Roentgenol. 2021 Mar 1. doi: 10.2214/AJR.20.25207.
    PubMed     Abstract available


    February 2021
  44. CHANG SD, Margolis DJA, Turkbey B, Arnold AA, et al
    Practice Patterns and Challenges of Performing and Interpreting Prostate MRI: A Survey by the Society of Abdominal Radiology Prostate Disease-Focused Panel.
    AJR Am J Roentgenol. 2021 Feb 10:1-8. doi: 10.2214/AJR.20.23256.
    PubMed     Abstract available


    July 2020
  45. GIGANTI F, Kirkham A, Allen C, Punwani S, et al
    Update on multiparametric prostate MRI during active surveillance: current and future trends and role of the PRECISE recommendations.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23985.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.